Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Vanda Pharmaceuticals Inc.    VNDA   US9216591084

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/13/2015 04/14/2015 04/15/2015 04/16/2015 04/17/2015 Date
9.57(c) 9.84(c) 10.04(c) 10.09(c) 9.9(c) Last
385 858 795 110 682 202 278 199 364 822 Volume
+0.53% +2.82% +2.03% +0.50% -1.88% Change
More quotes
Financials ($)
Sales 2015 103 M
EBIT 2015 -40,3 M
Net income 2015 -42,7 M
Debt 2015 -
Yield 2015 -
Sales 2016 148 M
EBIT 2016 -14,5 M
Net income 2016 -22,3 M
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 4,07x
Capi. / Sales 2016 2,83x
Capitalization 420 M
More Financials
Company
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders.Its product portfolio includes Fanapt and Tasimelteon.The Fanapt product is a compound for the treatment of schizophrenia, the... 
More about the company
Surperformance© ratings of Vanda Pharmaceuticals Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on VANDA PHARMACEUTICALS INC.
04/17 VANDA PHARMACEUTICALS : Reports Trial Date for Fanapt Patent Cases
04/16 VANDA PHARMACEUTICALS : to Announce First Quarter 2015 Financial Results on May ..
04/16 VANDA PHARMACEUTICALS : Announces Listing of a New Fanapt® Patent in the FDA Ora..
04/15 VANDA PHARMACEUTICALS : Patent Issued for Method of Treatment Based on Polymorph..
04/13 VANDA PHARMACEUTICALS : Announces Trial Date for Fanapt® Patent Cases
04/09 VANDA PHARMACEUTICALS : Announces Listing of a New Fanapt® Patent in the FDA Ora..
04/08 VANDA PHARMACEUTICALS : Assigned Patent
03/20 VANDA PHARMACEUTICALS : Change in Directors or Principal Officers (form 8-K)
More news
Sector news : Bio Therapeutic Drugs
04/17 INCYTE : Emerging Development Pipeline Described in Eleven Abstracts at 2015 AAC..
04/16 QIAGEN NV : N.V. : to Report First Quarter 2015 Results
04/16 QUINTILES TRANSNATIONAL : and Hospital Italiano of Buenos Aires Announce Agreeme..
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
03/05 Vanda Pharmaceuticals' Pipeline Goes Up In Smoke
03/04 After Hours Gainers / Losers
02/25 Vanda Pharmaceuticals May Not Make Sales Expectations
02/19 Vanda Pharmaceuticals' (VNDA) CEO Mihael Polymeropoulos on Q4 2014 Results - ..
02/19 Vanda Pharmaceuticals (VNDA) Q4 2014 Results - Earnings Call Webcast


Comments 
Advertisement
Chart VANDA PHARMACEUTICALS INC.
Duration : Period :
Vanda Pharmaceuticals Inc. Technical Analysis Chart | VNDA | US9216591084 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF